Download The IRA Disruption Report: A Strategic Look at Patient Access Changes

The Inflation Reduction Act (IRA) is shifting the access landscape. Are you ready?

The IRA Disruption Report delivers a strategic view of how the Inflation Reduction Act is reshaping coverage, patient out-of-pocket costs, and brand performance across the market.

Based on proprietary data, this report gives you a timely, comprehensive look at what’s changed. You’ll walk away with a deeper understanding of:

• IRA-driven coverage changes across Immunology, Oncology, and Endocrinology
• New prior auth, cost share, and formulary trends by brand and plan
• Geographic hotspots where access disruption is most severe
• Strategic takeaways for adapting patient support and payer engagement
• Actionable insights to guide localized, data-driven access planning

Want more targeted insight? We also offer custom reports tailored to your brand. Our team can help you dig into real-world data and uncover brand-specific impacts—so you can adjust strategy, support patients, and stay ahead of disruption.

Get the Report: